Rx (Prescription Medicine)
USD $ 109.00
Dasatib 100mg Tablet 是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分 Dasatinib 是一种酪氨酸激酶抑制剂（TKI）。它通过阻断特定酶的作用，即酪氨酸激酶，这些酶参与癌细胞的生长和增殖。通过抑制这些酶，Dasatib 能减缓或停止癌细胞肿瘤的生长，还能诱导癌细胞死亡。
Dasatib 100mg Tablet 主要适应症为慢性髓系白血病（CML）患者——对先前治疗不耐受或不耐受的患者，以及成人 Philadelphia 染色体阳性急性淋巴细胞白血病（Ph+ ALL）患者。典型的剂量和给药方案将由合格的医疗专业人员根据患者的具体情况、对治疗的反应以及其他个体因素来确定。务必严格按照医嘱服用此药。
常见不良反应可能包括水肿、腹泻、头痛、皮疹、疲劳、恶心和肌肉疼痛。更严重的不良反应也可能发生，如出现任何异常症状，患者应立即向医生报告。Dasatib 100mg Tablet 应储存在室温、远离潮湿和热源的地方，并放在儿童不易触及的地方。始终请咨询您的医疗提供者以获得个性化的医疗建议。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Dasatinib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
